Cell-specific cytotoxicity of dextran-stabilized magnetite nanoparticles

Colloids and Surfaces B: Biointerfaces

Volumn 79, Issue 1, 2010, Pages 184-190

  Ding, Jing ^a   Tao, Ke ^b   Li, Jiyu ^a   Song, Sheng ^b   Sun, Kang ^b  

^a XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Apoptosis; Cytotoxicity; Dextran; Flow cytometry; Magnetite nanoparticle

Indexed keywords

APOPTOSIS; BLOOD MONONUCLEAR CELLS; CELL SORTING; CYCLING PROCESS; MAGNETITE NANOPARTICLES; POLYOL METHODS; RAT LIVERS; RENAL CELL; TEM IMAGES;

CELL DEATH; CYTOTOXICITY; DEXTRAN; FLOW CYTOMETRY; GLUCOSE; LEAD; MAGNETITE; OXIDE MINERALS; SELF ASSEMBLY;

NANOPARTICLES;

DEXTRAN MAGNETITE; NANOPARTICLE;

ANIMAL CELL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; CYTOTOXICITY; ENDOCYTOSIS; FLUORESCENCE ACTIVATED CELL SORTING; KIDNEY CELL; LIVER CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RAT; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; APOPTOSIS; ASTROCYTES; CELL LINE; CELLS, CULTURED; DEXTRANS; DOSE-RESPONSE RELATIONSHIP, DRUG; FERROSOFERRIC OXIDE; FLOW CYTOMETRY; LEUKOCYTES, MONONUCLEAR; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, TRANSMISSION; RATS; RATS, SPRAGUE-DAWLEY; X-RAY DIFFRACTION;

RATTUS;

EID: 77952916810     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2010.03.053     Document Type: Article

References (36)

1. Pankhurst Q.A., Connolly J., Jones S.K., Dobson J. Applications of magnetic nanoparticles in biomedicine. J. Phys. D: Appl. Phys. 2003, 36:R167-R181.
2. Gupta A.K., Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 26:3995-4021.
3. Soto K., Garza K.M., Murr L.E. Cytotoxic effects of aggregated nanomaterials. Acta Biomater. 2007, 3:351-358.
4. Lewinski N., Colvin V., Drezek R. Cytotoxicity of nanoparticles. Small 2008, 4:26-49.
5. Gupta A.K., Wells S. Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies. IEEE Trans. Nanobiosci. 2004, 3:66-73.
6. Gupta A.K., Gupta M. Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles. Biomaterials 2005, 26:1565-1573.
7. Hu F., Neoh K., Cen L., Kang E. Cellular response to magnetic nanoparticles " PEGylated" via surface-initiated atom transfer radical polymerization. Biomacromolecules 2006, 7:809-816.
8. Petri-Fink A., Chastellain M., Juillerat-Jeanneret L., Ferrari A., Hofmann A. Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells. Biomaterials 2005, 26:2685-2694.
9. Cengelli F., Maysinger D., Tschudi-Monnet F., Montet F., Corot C., Petri-Fink A., Hofmann H., Juillerat-Jeanneret L. Interaction of functionalized superparamagnetic iron oxide nanoparticles with brain structures. J. Pharmacol. Exp. Ther. 2006, 318:108-116.
10. Jordan A., Scholz R., Wust P., Schirra H., Schiestel T., Schmidt H., Felix R. Endocytosis of dextran and silan-coated magnetite nanoparticles and the effect of intracellular hyperthermia on human mammary carcinoma cells in vitro. J. Magn. Magn. Mater. 1999, 194:185-196.
11. Yu W.W., Chang E., Sayes C.M., Drezek R., Colvin V.L. Aqueous dispersion of monodisperse magnetic iron oxide nanocrystals through phase transfer. Nanotechnology 2006, 17:4483-4487.
12. Muller K., Skeppera J., Posfaib M., Trivedi R., Howarth S., Corot C., Lancelot E., Thompson P., Brown A., Gillard J. Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro. Biomaterials 2007, 28:1629-1642.
13. 4 nanoparticles and their biomedical applications. Biomaterials 2005, 26:729-738.
14. Ito A., Ino K., Kobayashi T., Honda H. The effect of RGD peptide-conjugated magnetite cationic liposomes on cell growth and cell sheet harvesting. Biomaterials 2005, 26:6185-6193.
15. Zhang Y., Kohler N., Zhang M. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 2002, 23:1553-1561.
16. Lee H., Lee E., Kim D.K., Jang N.K., Jeong Y.Y., Jon S. Antibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imaging. J. Am. Chem. Soc. 2006, 128:7383-7389.
17. Thoren L. The dextrans-clinical data. Dev. Biol. Stand. 1981, 48:157-167.
18. Mehvar R. Dextrans for targeted and sustained delivery of therapeutic and imaging agents. J. Control. Rel. 2000, 69:1-25.
19. Jung C.W. Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxil. Magn. Reson. Imag. 1995, 13:675-691.
20. King M. Detection of dead cells and measurement of cell killing by flow cytometry. J. Immunol. Methods 2000, 243:155-166.
21. Darzynkiewicz Z., Bruno S., Del Bino G., Gorczyca W., Hotz M.A., Lassota P., Traganos F. Features of apoptotic cells measured by flow cytometry. Cytometry 1992, 13:795-808.
22. Kostarelos K., Lacerda L., Pastorin G., Wu W., Kieckowski S., Luangsivilay J., Godefroy S., Pantarotto D., Briand J., Muller S., Prato M., Bianco A. Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. Nat. Nanotechnol. 2007, 2:108-113.
23. Kam N., Jessop T., Wender P., Dai H. Nanotube molecular transporters: internalization of carbon nanotube-protein conjugates into mammalian cells. J. Am. Chem. Soc. 2004, 126:6850-6851.
24. 4 clusters. Colloid Surf. A 2006, 290:70-76.
25. Bourlinos A.B., Bakandritsos A., Georgakilas V., Petridis D. Surface modification of ultrafine magnetic iron oxide particles. Chem. Mater. 2002, 14:3226-3228.
26. Ge J., Hu Y., Biasini M., Dong C., Guo J., Beyermann W.P., Yin Y. One-step synthesis of highly water-soluble magnetite colloidal nanocrystals. Chem. Eur. J. 2007, 13:7153-7161.
27. Daldrup-Link H.E., Rudelius M., Oostendorp R.A.J., Settles M., Pionteck G., Metz S. Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology 2003, 228:760-767.
28. Schulze E., Ferrucci J.T., Poss K., Lapointe L., Bogdanova A., Weissleder R. Cellular uptake and trafficking of a prototypical magnetic iron oxide label in vitro. Investig. Radiol. 1995, 10:604-610.
29. Hussain S.M., Hess K.L., Gearhart J.M., Geiss K.T., Schlager J.J. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol. In Vitro 2005, 19:975-983.
30. Fleige G., Nolte C., Synowitz M., Seeberger F., Kettenmann H., Zimmer C. Magnetic labeling of activated microglia in experimental gliomas. Neoplasia 2001, 3:489-499.
31. Berry C.C., Well S., Charles S., Aichison G., Curtis A.S.G. Cell response to dextran-derivatised iron oxide nanoparticles post internalization. Biomaterials 2004, 25:5405-5413.
32. Metz S., Bonaterra G., Rudelius M., Settles M., Rummeny E.J., Daldrup-Link H.E. Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur. Radiol. 2004, 14:1851-1858.
33. Arbab A.S., Bashaw L.A., Miller B.R., Jordan E.K., Bulte J.W.M., Frank J.A. Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques. Transplantation 2003, 76:1123-1130.
34. Arbab A.S., Yocum G.T., Kalish H., Jordan E.K., Anderson S.A., Khakoo A.Y., Read E.J., Frank J.A. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 2004, 104:1217-1223.
35. Brunner T., Wick P., Manser P., Spohn P., Grass R., Limbach L., Bruinink A., Stark W. In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ. Sci. Technol. 2006, 40:4374-4381.
36. Kohler N., Sun C., Wang J., Zhang J. Methotrexate-modified superparamagnetic nanoparticles and their Intracellular uptake into human cancer cells. Langmuir 2005, 21:8858-8864.